Caroline Robert Selected Research

Caroline Robert Research Topics

Disease

250	Melanoma (Melanoma, Malignant) 05/2024 - 03/2004
162	Neoplasms (Cancer) 02/2024 - 03/2004
37	Neoplasm Metastasis (Metastasis) 03/2024 - 03/2004
19	Disease Progression 01/2021 - 06/2011
12	Fatigue 10/2021 - 06/2009
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2009
11	Brain Neoplasms (Brain Tumor) 01/2024 - 11/2012
11	Fever (Fevers) 11/2023 - 02/2013
9	Basal Cell Carcinoma (Rodent Ulcer) 10/2023 - 12/2019
9	Exanthema (Rash) 01/2023 - 02/2009
9	Nausea 10/2021 - 06/2011
7	Colitis 01/2023 - 05/2015
7	Body Weight (Weight, Body) 11/2016 - 08/2010
7	Keratoacanthoma 01/2015 - 08/2009
6	Diarrhea 10/2021 - 06/2009
6	Lymphatic Metastasis 11/2020 - 10/2010
6	Neutropenia 06/2020 - 11/2012
5	Myocarditis (Carditis) 05/2024 - 05/2015
5	Pain (Aches) 02/2024 - 03/2009
5	Dermatitis 12/2023 - 01/2012
5	Hepatitis 11/2023 - 01/2018
5	Carcinogenesis 01/2023 - 10/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 06/2016
5	Inflammation (Inflammations) 01/2022 - 02/2002
5	Renal Cell Carcinoma (Grawitz Tumor) 10/2014 - 03/2007
4	Skin Neoplasms (Skin Cancer) 05/2023 - 03/2011
4	Hypertension (High Blood Pressure) 11/2022 - 02/2009
4	Arthralgia (Joint Pain) 01/2020 - 06/2011
3	Sarcoidosis (Schaumann Disease) 06/2022 - 10/2021
3	COVID-19 01/2022 - 01/2020
3	Alopecia (Baldness) 10/2021 - 02/2009
3	Myalgia 10/2018 - 08/2015
3	Vomiting 05/2015 - 01/2012
3	Hemangioma (Angioma) 02/2012 - 11/2009
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2009 - 08/2004
2	Myositis (Idiopathic Inflammatory Myopathies) 05/2024 - 05/2018

Drug/Important Bio-Agent (IBA)

65	IpilimumabIBA 02/2024 - 08/2010
60	pembrolizumabIBA 03/2024 - 07/2013
55	Immune Checkpoint InhibitorsIBA 02/2024 - 07/2013
42	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2024 - 01/2012
30	NivolumabIBA 05/2024 - 01/2015
28	dabrafenibIBA 01/2023 - 11/2012
28	trametinibIBA 01/2023 - 07/2012
25	VemurafenibIBA 04/2024 - 06/2011
25	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2007
18	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 06/2009
17	Monoclonal AntibodiesIBA 01/2020 - 08/2008
16	AntibodiesIBA 12/2023 - 03/2004
13	encorafenibIBA 04/2024 - 09/2017
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2012
13	Sorafenib (BAY 43-9006)FDA Link 04/2014 - 03/2007
12	binimetinibIBA 04/2024 - 01/2018
11	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023 - 01/2016
10	AntigensIBA 10/2022 - 03/2004
10	LigandsIBA 01/2019 - 02/2002
9	InterferonsIBA 10/2022 - 10/2010
9	Phosphotransferases (Kinase)IBA 01/2021 - 07/2005
8	B7-H1 AntigenIBA 01/2023 - 12/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2008
7	Eukaryotic Initiation Factor-4F (EIF4F)IBA 01/2023 - 09/2014
6	cobimetinibIBA 12/2023 - 01/2019
5	atezolizumabIBA 12/2023 - 03/2014
5	Mitogen-Activated Protein KinasesIBA 10/2022 - 04/2014
5	CTLA-4 AntigenIBA 10/2021 - 08/2009
4	sonidegibIBA 06/2023 - 10/2021
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 01/2018
4	Messenger RNA (mRNA)IBA 02/2022 - 10/2015
4	Immune Checkpoint ProteinsIBA 02/2022 - 08/2014
4	HhAntag691IBA 01/2022 - 12/2019
4	Temozolomide (Temodar)FDA LinkGeneric 01/2014 - 06/2009
4	Peptides (Polypeptides)IBA 09/2013 - 03/2005
4	Imatinib Mesylate (Gleevec)FDA Link 02/2013 - 08/2004
4	Sunitinib (Sutent)FDA Link 02/2009 - 01/2006
3	SteroidsIBA 01/2024 - 10/2017
3	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2019
3	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2023 - 01/2012
3	ChemokinesIBA 01/2023 - 06/2011
3	CytokinesIBA 01/2023 - 06/2016
3	Protein Isoforms (Isoforms)IBA 12/2022 - 08/2004
3	Lipase (Acid Lipase)FDA Link 11/2022 - 11/2012
3	spartalizumabIBA 01/2022 - 10/2020
3	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2019
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2020 - 10/2019
3	Alanine Transaminase (SGPT)IBA 01/2020 - 11/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2009
3	tremelimumabIBA 06/2017 - 08/2008
3	Microphthalmia-Associated Transcription FactorIBA 01/2017 - 04/2008
3	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2017 - 09/2008
3	InterleukinsIBA 06/2016 - 02/2013
3	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2006
2	Bispecific AntibodiesIBA 12/2023 - 10/2022

Therapy/Procedure

138	Therapeutics 03/2024 - 11/2004
70	Immunotherapy 04/2024 - 03/2004
18	Drug Therapy (Chemotherapy) 01/2022 - 11/2004
9	Radiotherapy 11/2021 - 11/2009
6	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 01/2018
3	Aftercare (After-Treatment) 02/2024 - 03/2011
3	Ligation 01/2022 - 11/2014
3	Duration of Therapy 11/2020 - 03/2009
3	Intravenous Infusions 01/2019 - 11/2016